Related Experiment Videos
Variation in tumor doubling time in patients with pulmonary metastatic disease
Journal of Surgical Oncology
|January 1, 1971
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Immunology of gangliosides.
Indian journal of experimental biology·2001
Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma.
CA: a cancer journal for clinicians·2001
Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I-III melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2000
Ewing's Sarcoma in Adults: A Predictive Nomogram and Survival Analysis of a Cohort of 937 Patients.
Journal of surgical oncology·2026
Treatment Selection and Survival In Muscle-Invasive Bladder Cancer: Real-World Data on the Impact of Geriatric-8 Screening.
Journal of surgical oncology·2026
Fixing A Problem That May Not Exist: 3N2 + 1N1 Mandate Prioritizes Compliance Over Safety.
Journal of surgical oncology·2026
Factors Associated With Receipt of Adjuvant Radiation in Locally Advanced Rectal Cancer.
Journal of surgical oncology·2026
Immunogenic Cell Death-Associated miRNAs in the Tumor Microenvironment of Hepatocellular Carcinoma.
Journal of surgical oncology·2026
Hypoxia-Induced Expression of miR-424, miR-155, CD47, and PD-L1 in a Gastric Cancer Cell Line (MKN-45).
Iranian biomedical journal·2026
Long-term safety of first-line osimertinib plus platinum-pemetrexed in EGFR-mutated advanced NSCLC: FLAURA2.
Lung cancer (Amsterdam, Netherlands)·2026